Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayoko Tao

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
American Journal of Human Genetics|June 6, 2022
Comprehensive evaluation and efficient classification of BRCA1 RING domain missense substitutionsKathleen A Clark, Andrew Paquette, Kayoko Tao, et al.
Arthritis and Rheumatism|June 26, 2008
Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese populationShu Kobayashi, Katsunori Ikari, Hirotaka Kaneko, et al.
Breast Cancer Research : BCR|June 5, 2014
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening studyFrancesca Damiola, Maroulio Pertesi, Javier Oliver, et al.
JCO Precision Oncology|July 6, 2023
Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR ProjectKayoko Tao, Fumito Yamazaki, Takashi Kubo, et al.
International Journal of Clinical Oncology|May 22, 2023
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumorsYoichi Naito, Saori Mishima, Kiwamu Akagi, et al.
International Journal of Clinical Oncology|August 20, 2023
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third editionSaori Mishima, Yoichi Naito, Kiwamu Akagi, et al.
International Journal of Clinical Oncology|June 10, 2023
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumorsSaori Mishima, Yoichi Naito, Kiwamu Akagi, et al.
Cancer Science|November 17, 2025
Genomic Profiling of Pediatric Solid Tumors With a Dual DNA/RNA Panel: JCCG-TOP2 StudyKayoko Tao, Takako Yoshioka, Miho Kato, et al.
Cancer Discovery|July 23, 2014
Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancersDaniel J Park, Kayoko Tao, Florence Le Calvez-Kelm, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 5, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Human Genetics|June 6, 2022
Comprehensive evaluation and efficient classification of BRCA1 RING domain missense substitutionsKathleen A Clark, Andrew Paquette, Kayoko Tao, et al.
Arthritis and Rheumatism|June 26, 2008
Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese populationShu Kobayashi, Katsunori Ikari, Hirotaka Kaneko, et al.
Breast Cancer Research : BCR|June 5, 2014
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening studyFrancesca Damiola, Maroulio Pertesi, Javier Oliver, et al.
JCO Precision Oncology|July 6, 2023
Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR ProjectKayoko Tao, Fumito Yamazaki, Takashi Kubo, et al.
International Journal of Clinical Oncology|May 22, 2023
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumorsYoichi Naito, Saori Mishima, Kiwamu Akagi, et al.
International Journal of Clinical Oncology|August 20, 2023
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third editionSaori Mishima, Yoichi Naito, Kiwamu Akagi, et al.
International Journal of Clinical Oncology|June 10, 2023
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumorsSaori Mishima, Yoichi Naito, Kiwamu Akagi, et al.
Cancer Science|November 17, 2025
Genomic Profiling of Pediatric Solid Tumors With a Dual DNA/RNA Panel: JCCG-TOP2 StudyKayoko Tao, Takako Yoshioka, Miho Kato, et al.
Cancer Discovery|July 23, 2014
Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancersDaniel J Park, Kayoko Tao, Florence Le Calvez-Kelm, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 5, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Pageof 4